EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immune checkpoint inhibitor induces cardiac injury by impairing efferocytosis of macrophages via MerTK cleavage

Yu Zhang, Zhenzhu Cao, Huihui Jia, Yuting Feng, Xuan Sun, Han Wu, Biao Xu, Zhonghai Wei

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, 358 Zhon…. Hauptthemen laut MEDLINE: c-Mer Tyrosine Kinase, Macrophages, Immune Checkpoint Inhibitors, Myocarditis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy is a well-established therapeutic approach for various types of cancer. However, its clinical utility is usually limited by cardiovascular adverse events. Immune Checkpoint Inhibitors (ICIs) can induce diverse forms of cardiotoxicity, with myocarditis being the most fatal complication. The underlying mechanism of its occurrence remains elusive. Therefore, this study aims to elucidate the impact of programmed death-1 (PD-1) inhibitor on myocarditis development in mice. Myeloid-epithelial-reproductive tyrosine kinase (MerTK) receptors, located on the surface of macrophages, play a pivotal role in phagocytic regulation. We established a mouse model of autoimmune myocarditis by injecting 6-week-old normal male BALB/c mice with PD-1 inhibitor and cardiac troponin I peptide fragments, which resulted in elevated levels of serum soluble MerTK (SolMer) and reduced numbers of MerTK-CD68 double-positive macrophages, accompanied by cardiac injury in mice. In vitro, PD-1 inhibitor promotes a disintegrin and metalloproteinase17 (ADAM17)-mediated shed of the MerTK, forming SolMer, through MKK3/P38 MAPK pathway, leading to downregulation of MerTK expression on the macrophage surface. This results in the inhibition of efferocytosis and impairment of tissue repair function, ultimately contributing to myocarditis development. TAPI-0 inhibited the activity of ADAM17, while SB203580 inhibited the phosphorylation of P38 MAPK. Both inhibitors effectively restored the inhibition of efferocytosis induced by the PD-1 inhibitor. In vitro, when the PD-1 receptor on the surface of RAW264.7 macrophages was knocked down and then stimulated with a PD-1 inhibitor, no further significant alterations in the pathway were elicited. In conclusion, the PD-1 inhibitor induces the shedding of MerTK in macrophages by binding to the PD-1 receptor on the surface of macrophages and activating the MKK3/P38 MAPK/ADAM17 pathway, leading to impaired efferocytosis. Elucidation of this molecular mechanism holds promise for improved prognosis and therapeutic strategies in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

c-Mer Tyrosine KinaseMacrophagesImmune Checkpoint InhibitorsMyocarditisAutoimmune DiseasesAnimalsMaleMiceMice, Inbred BALB CPhagocytosisADAM17 ProteinDisease Models, AnimalHumansProgrammed Cell Death 1 ReceptorEfferocytosis

Stichwörter der Autor:innen

EfferocytosisImmune Checkpoint Inhibitor-Associated MyocarditisMacrophageMerTK

Substanzen

c-Mer Tyrosine KinaseMertk protein, mouseImmune Checkpoint InhibitorsADAM17 ProteinProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Cardiology, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, 358 Zhongshan Road 210008 Nanjing, China.
  • Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008 China.
  • Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008 China. Electronic address: njumed@163.com.
  • Department of Cardiology, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, 358 Zhongshan Road 210008 Nanjing, China; Department of Cardiology, Nanjing Dr…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Zhang, Y., Cao, Z., Jia, H., Feng, Y., Sun, X., Wu, H., Xu, B., & Wei, Z. (2025). Immune checkpoint inhibitor induces cardiac injury by impairing efferocytosis of macrophages via MerTK cleavage. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114263

Vancouver

Zhang Y, Cao Z, Jia H, Feng Y, Sun X, Wu H, et al. Immune checkpoint inhibitor induces cardiac injury by impairing efferocytosis of macrophages via MerTK cleavage. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114263

BibTeX
@article{Zhang2025,
  author = {Zhang, Yu and Cao, Zhenzhu and Jia, Huihui and Feng, Yuting and Sun, Xuan and Wu, Han and Xu, Biao and Wei, Zhonghai},
  title = {Immune checkpoint inhibitor induces cardiac injury by impairing efferocytosis of macrophages via MerTK cleavage},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114263}
}
Kostenlos starten →